> top > projects > spacy-test > docs > PubMed:3926664 > annotations
spacy-test Home  

PubMed:3926664 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-3 DT denotes The
spaCy_T1 4-10 NN denotes effect
spaCy_T2 11-13 IN denotes of
spaCy_T3 14-24 NNS denotes progestins
spaCy_T4 25-27 IN denotes on
spaCy_T5 28-31 DT denotes the
spaCy_T6 32-39 JJ denotes mitotic
spaCy_T7 40-48 NN denotes activity
spaCy_T8 49-51 IN denotes of
spaCy_T9 52-59 JJ denotes uterine
spaCy_T10 60-71 NNS denotes fibromyomas
spaCy_T11 71-72 . denotes .
spaCy_T12 73-81 JJ denotes Previous
spaCy_T13 82-89 NNS denotes studies
spaCy_T14 90-94 VBP denotes have
spaCy_T15 95-100 VBN denotes shown
spaCy_T16 101-110 VBN denotes increased
spaCy_T17 111-118 JJ denotes mitotic
spaCy_T18 119-127 NN denotes activity
spaCy_T19 128-130 IN denotes in
spaCy_T20 131-138 JJ denotes uterine
spaCy_T21 139-150 NNS denotes fibromyomas
spaCy_T22 151-153 IN denotes in
spaCy_T23 154-162 NNS denotes patients
spaCy_T24 163-168 VBG denotes using
spaCy_T25 169-178 JJ denotes exogenous
spaCy_T26 179-187 NNS denotes hormones
spaCy_T27 187-188 . denotes .
spaCy_T28 189-193 DT denotes This
spaCy_T29 194-199 NN denotes study
spaCy_T30 200-203 VBZ denotes has
spaCy_T31 204-212 VBN denotes compared
spaCy_T32 213-216 DT denotes the
spaCy_T33 217-224 JJ denotes mitotic
spaCy_T34 225-233 NN denotes activity
spaCy_T35 234-236 IN denotes of
spaCy_T36 237-248 NNS denotes fibromyomas
spaCy_T37 249-251 IN denotes in
spaCy_T38 252-257 CD denotes three
spaCy_T39 258-264 NNS denotes groups
spaCy_T40 265-267 IN denotes of
spaCy_T41 268-276 NNS denotes patients
spaCy_T42 276-277 . denotes .
spaCy_T43 278-281 DT denotes The
spaCy_T44 282-287 JJ denotes first
spaCy_T45 288-293 NN denotes group
spaCy_T46 294-297 VBD denotes was
spaCy_T47 298-303 VBG denotes using
spaCy_T48 304-305 DT denotes a
spaCy_T49 306-320 JJ denotes progestin-only
spaCy_T50 321-332 NN denotes preparation
spaCy_T51 333-334 -LRB- denotes (
spaCy_T52 334-341 RB denotes usually
spaCy_T53 342-366 JJ denotes depo-medroxyprogesterone
spaCy_T54 367-374 NN denotes acetate
spaCy_T55 374-375 -RRB- denotes )
spaCy_T56 375-376 . denotes .
spaCy_T57 377-380 DT denotes The
spaCy_T58 381-387 JJ denotes second
spaCy_T59 388-393 NN denotes group
spaCy_T60 394-396 IN denotes of
spaCy_T61 397-408 JJ denotes age-matched
spaCy_T62 409-417 NNS denotes controls
spaCy_T63 418-421 VBD denotes had
spaCy_T64 422-427 RB denotes never
spaCy_T65 428-432 VBN denotes used
spaCy_T66 433-436 DT denotes any
spaCy_T67 437-446 JJ denotes exogenous
spaCy_T68 447-454 NN denotes hormone
spaCy_T69 454-455 . denotes .
spaCy_T70 456-459 DT denotes The
spaCy_T71 460-465 JJ denotes third
spaCy_T72 466-471 NN denotes group
spaCy_T73 472-474 IN denotes of
spaCy_T74 475-483 NNS denotes patients
spaCy_T75 484-487 VBD denotes was
spaCy_T76 488-493 VBG denotes using
spaCy_T77 494-495 DT denotes a
spaCy_T78 496-504 VBN denotes combined
spaCy_T79 505-523 NN denotes estrogen/progestin
spaCy_T80 524-528 JJ denotes oral
spaCy_T81 529-542 NN denotes contraceptive
spaCy_T82 542-543 . denotes .
spaCy_T83 544-547 DT denotes The
spaCy_T84 548-555 NNS denotes results
spaCy_T85 556-560 VBP denotes show
spaCy_T86 561-565 IN denotes that
spaCy_T87 566-574 NNS denotes patients
spaCy_T88 575-580 VBG denotes using
spaCy_T89 581-582 DT denotes a
spaCy_T90 583-597 JJ denotes progestin-only
spaCy_T91 598-609 NN denotes preparation
spaCy_T92 610-614 VBP denotes have
spaCy_T93 615-616 DT denotes a
spaCy_T94 617-630 RB denotes significantly
spaCy_T95 631-637 JJR denotes higher
spaCy_T96 638-645 JJ denotes mitotic
spaCy_T97 646-654 NN denotes activity
spaCy_T98 655-657 IN denotes in
spaCy_T99 658-669 NNS denotes fibromyomas
spaCy_T100 670-674 IN denotes than
spaCy_T101 675-683 NNS denotes patients
spaCy_T102 684-688 IN denotes from
spaCy_T103 689-692 DT denotes the
spaCy_T104 693-698 JJ denotes other
spaCy_T105 699-702 CD denotes two
spaCy_T106 703-709 NNS denotes groups
spaCy_T107 709-710 : denotes ;
spaCy_T108 711-718 NNS denotes results
spaCy_T109 719-723 IN denotes from
spaCy_T110 724-732 NNS denotes patients
spaCy_T111 733-738 VBG denotes using
spaCy_T112 739-740 DT denotes a
spaCy_T113 741-749 VBN denotes combined
spaCy_T114 750-768 NN denotes estrogen/progestin
spaCy_T115 769-780 NN denotes preparation
spaCy_T116 781-785 VBD denotes were
spaCy_T117 786-789 DT denotes the
spaCy_T118 790-794 JJ denotes same
spaCy_T119 795-797 IN denotes as
spaCy_T120 798-801 DT denotes the
spaCy_T121 802-810 NNS denotes controls
spaCy_T122 810-811 . denotes .
spaCy_T123 812-815 DT denotes The
spaCy_T124 816-823 JJS denotes highest
spaCy_T125 824-829 NN denotes count
spaCy_T126 830-833 VBD denotes was
spaCy_T127 834-836 CD denotes 39
spaCy_T128 837-848 CD denotes mitoses/100
spaCy_T129 849-853 JJ denotes high
spaCy_T130 854-859 NN denotes power
spaCy_T131 860-866 NNS denotes fields
spaCy_T132 867-868 -LRB- denotes (
spaCy_T133 868-871 NNP denotes HPF
spaCy_T134 871-872 -RRB- denotes )
spaCy_T135 872-873 , denotes ,
spaCy_T136 874-877 CC denotes but
spaCy_T137 878-883 JJ denotes focal
spaCy_T138 884-889 NNS denotes areas
spaCy_T139 890-900 VBG denotes containing
spaCy_T140 901-903 RP denotes up
spaCy_T141 904-906 TO denotes to
spaCy_T142 907-908 CD denotes 8
spaCy_T143 909-919 CD denotes mitoses/10
spaCy_T144 920-923 NNP denotes HPF
spaCy_T145 924-929 MD denotes could
spaCy_T146 930-932 VB denotes be
spaCy_T147 933-938 VBN denotes found
spaCy_T148 938-939 . denotes .
spaCy_T149 940-942 IN denotes In
spaCy_T150 943-947 NN denotes none
spaCy_T151 948-950 IN denotes of
spaCy_T152 951-954 DT denotes the
spaCy_T153 955-966 NNS denotes fibromyomas
spaCy_T154 967-975 VBD denotes examined
spaCy_T155 976-979 VBD denotes did
spaCy_T156 980-983 DT denotes the
spaCy_T157 984-989 NN denotes count
spaCy_T158 990-996 VBP denotes exceed
spaCy_T159 997-999 CD denotes 10
spaCy_T160 1000-1010 JJ denotes mitoses/10
spaCy_T161 1011-1014 NNP denotes HPF
spaCy_T162 1014-1015 , denotes ,
spaCy_T163 1016-1019 CC denotes and
spaCy_T164 1020-1024 NN denotes none
spaCy_T165 1025-1031 VBD denotes showed
spaCy_T166 1032-1043 JJ denotes significant
spaCy_T167 1044-1056 NN denotes pleomorphism
spaCy_T168 1057-1061 WDT denotes that
spaCy_T169 1062-1067 MD denotes might
spaCy_T170 1068-1072 VB denotes have
spaCy_T171 1073-1077 VBN denotes been
spaCy_T172 1078-1086 VBN denotes confused
spaCy_T173 1087-1091 IN denotes with
spaCy_T174 1092-1102 NN denotes malignancy
spaCy_T175 1102-1103 . denotes .
spaCy_R0 spaCy_T0 spaCy_T1 det The,effect
spaCy_R1 spaCy_T1 spaCy_T1 ROOT effect,effect
spaCy_R10 spaCy_T10 spaCy_T8 pobj fibromyomas,of
spaCy_R100 spaCy_T100 spaCy_T97 prep than,activity
spaCy_R101 spaCy_T101 spaCy_T100 pobj patients,than
spaCy_R102 spaCy_T102 spaCy_T101 prep from,patients
spaCy_R103 spaCy_T103 spaCy_T106 det the,groups
spaCy_R104 spaCy_T104 spaCy_T106 amod other,groups
spaCy_R105 spaCy_T105 spaCy_T106 nummod two,groups
spaCy_R106 spaCy_T106 spaCy_T102 pobj groups,from
spaCy_R107 spaCy_T107 spaCy_T116 punct ;,were
spaCy_R108 spaCy_T108 spaCy_T116 nsubj results,were
spaCy_R109 spaCy_T109 spaCy_T108 prep from,results
spaCy_R11 spaCy_T11 spaCy_T1 punct .,effect
spaCy_R110 spaCy_T110 spaCy_T109 pobj patients,from
spaCy_R111 spaCy_T111 spaCy_T108 acl using,results
spaCy_R112 spaCy_T112 spaCy_T115 det a,preparation
spaCy_R113 spaCy_T113 spaCy_T115 amod combined,preparation
spaCy_R114 spaCy_T114 spaCy_T115 compound estrogen/progestin,preparation
spaCy_R115 spaCy_T115 spaCy_T111 dobj preparation,using
spaCy_R116 spaCy_T116 spaCy_T116 ROOT were,were
spaCy_R117 spaCy_T117 spaCy_T118 det the,same
spaCy_R118 spaCy_T118 spaCy_T116 attr same,were
spaCy_R119 spaCy_T119 spaCy_T118 prep as,same
spaCy_R12 spaCy_T12 spaCy_T13 amod Previous,studies
spaCy_R120 spaCy_T120 spaCy_T121 det the,controls
spaCy_R121 spaCy_T121 spaCy_T119 pobj controls,as
spaCy_R122 spaCy_T122 spaCy_T116 punct .,were
spaCy_R123 spaCy_T123 spaCy_T125 det The,count
spaCy_R124 spaCy_T124 spaCy_T125 amod highest,count
spaCy_R125 spaCy_T125 spaCy_T126 nsubj count,was
spaCy_R126 spaCy_T126 spaCy_T126 ROOT was,was
spaCy_R127 spaCy_T127 spaCy_T128 nummod 39,mitoses/100
spaCy_R128 spaCy_T128 spaCy_T131 nummod mitoses/100,fields
spaCy_R129 spaCy_T129 spaCy_T130 amod high,power
spaCy_R13 spaCy_T13 spaCy_T15 nsubj studies,shown
spaCy_R130 spaCy_T130 spaCy_T131 compound power,fields
spaCy_R131 spaCy_T131 spaCy_T126 attr fields,was
spaCy_R132 spaCy_T132 spaCy_T131 punct (,fields
spaCy_R133 spaCy_T133 spaCy_T131 appos HPF,fields
spaCy_R134 spaCy_T134 spaCy_T131 punct ),fields
spaCy_R135 spaCy_T135 spaCy_T126 punct ",",was
spaCy_R136 spaCy_T136 spaCy_T126 cc but,was
spaCy_R137 spaCy_T137 spaCy_T138 amod focal,areas
spaCy_R138 spaCy_T138 spaCy_T147 nsubjpass areas,found
spaCy_R139 spaCy_T139 spaCy_T138 acl containing,areas
spaCy_R14 spaCy_T14 spaCy_T15 aux have,shown
spaCy_R140 spaCy_T140 spaCy_T139 prt up,containing
spaCy_R141 spaCy_T141 spaCy_T142 nmod to,8
spaCy_R142 spaCy_T142 spaCy_T144 nummod 8,HPF
spaCy_R143 spaCy_T143 spaCy_T144 nummod mitoses/10,HPF
spaCy_R144 spaCy_T144 spaCy_T139 dobj HPF,containing
spaCy_R145 spaCy_T145 spaCy_T147 aux could,found
spaCy_R146 spaCy_T146 spaCy_T147 auxpass be,found
spaCy_R147 spaCy_T147 spaCy_T126 conj found,was
spaCy_R148 spaCy_T148 spaCy_T147 punct .,found
spaCy_R149 spaCy_T149 spaCy_T154 prep In,examined
spaCy_R15 spaCy_T15 spaCy_T15 ROOT shown,shown
spaCy_R150 spaCy_T150 spaCy_T149 pobj none,In
spaCy_R151 spaCy_T151 spaCy_T150 prep of,none
spaCy_R152 spaCy_T152 spaCy_T153 det the,fibromyomas
spaCy_R153 spaCy_T153 spaCy_T151 pobj fibromyomas,of
spaCy_R154 spaCy_T154 spaCy_T154 ROOT examined,examined
spaCy_R155 spaCy_T155 spaCy_T158 aux did,exceed
spaCy_R156 spaCy_T156 spaCy_T157 det the,count
spaCy_R157 spaCy_T157 spaCy_T158 nsubj count,exceed
spaCy_R158 spaCy_T158 spaCy_T154 ccomp exceed,examined
spaCy_R159 spaCy_T159 spaCy_T161 nummod 10,HPF
spaCy_R16 spaCy_T16 spaCy_T18 amod increased,activity
spaCy_R160 spaCy_T160 spaCy_T161 compound mitoses/10,HPF
spaCy_R161 spaCy_T161 spaCy_T158 dobj HPF,exceed
spaCy_R162 spaCy_T162 spaCy_T158 punct ",",exceed
spaCy_R163 spaCy_T163 spaCy_T158 cc and,exceed
spaCy_R164 spaCy_T164 spaCy_T165 nsubj none,showed
spaCy_R165 spaCy_T165 spaCy_T154 conj showed,examined
spaCy_R166 spaCy_T166 spaCy_T167 amod significant,pleomorphism
spaCy_R167 spaCy_T167 spaCy_T165 dobj pleomorphism,showed
spaCy_R168 spaCy_T168 spaCy_T172 nsubj that,confused
spaCy_R169 spaCy_T169 spaCy_T172 aux might,confused
spaCy_R17 spaCy_T17 spaCy_T18 amod mitotic,activity
spaCy_R170 spaCy_T170 spaCy_T172 aux have,confused
spaCy_R171 spaCy_T171 spaCy_T172 auxpass been,confused
spaCy_R172 spaCy_T172 spaCy_T167 relcl confused,pleomorphism
spaCy_R173 spaCy_T173 spaCy_T172 prep with,confused
spaCy_R174 spaCy_T174 spaCy_T173 pobj malignancy,with
spaCy_R175 spaCy_T175 spaCy_T165 punct .,showed
spaCy_R18 spaCy_T18 spaCy_T15 dobj activity,shown
spaCy_R19 spaCy_T19 spaCy_T15 prep in,shown
spaCy_R2 spaCy_T2 spaCy_T1 prep of,effect
spaCy_R20 spaCy_T20 spaCy_T21 compound uterine,fibromyomas
spaCy_R21 spaCy_T21 spaCy_T19 pobj fibromyomas,in
spaCy_R22 spaCy_T22 spaCy_T15 prep in,shown
spaCy_R23 spaCy_T23 spaCy_T22 pobj patients,in
spaCy_R24 spaCy_T24 spaCy_T15 advcl using,shown
spaCy_R25 spaCy_T25 spaCy_T26 amod exogenous,hormones
spaCy_R26 spaCy_T26 spaCy_T24 dobj hormones,using
spaCy_R27 spaCy_T27 spaCy_T15 punct .,shown
spaCy_R28 spaCy_T28 spaCy_T29 det This,study
spaCy_R29 spaCy_T29 spaCy_T31 nsubj study,compared
spaCy_R3 spaCy_T3 spaCy_T2 pobj progestins,of
spaCy_R30 spaCy_T30 spaCy_T31 aux has,compared
spaCy_R31 spaCy_T31 spaCy_T31 ROOT compared,compared
spaCy_R32 spaCy_T32 spaCy_T34 det the,activity
spaCy_R33 spaCy_T33 spaCy_T34 amod mitotic,activity
spaCy_R34 spaCy_T34 spaCy_T31 dobj activity,compared
spaCy_R35 spaCy_T35 spaCy_T34 prep of,activity
spaCy_R36 spaCy_T36 spaCy_T35 pobj fibromyomas,of
spaCy_R37 spaCy_T37 spaCy_T31 prep in,compared
spaCy_R38 spaCy_T38 spaCy_T39 nummod three,groups
spaCy_R39 spaCy_T39 spaCy_T37 pobj groups,in
spaCy_R4 spaCy_T4 spaCy_T3 prep on,progestins
spaCy_R40 spaCy_T40 spaCy_T39 prep of,groups
spaCy_R41 spaCy_T41 spaCy_T40 pobj patients,of
spaCy_R42 spaCy_T42 spaCy_T31 punct .,compared
spaCy_R43 spaCy_T43 spaCy_T45 det The,group
spaCy_R44 spaCy_T44 spaCy_T45 amod first,group
spaCy_R45 spaCy_T45 spaCy_T47 nsubj group,using
spaCy_R46 spaCy_T46 spaCy_T47 aux was,using
spaCy_R47 spaCy_T47 spaCy_T47 ROOT using,using
spaCy_R48 spaCy_T48 spaCy_T50 det a,preparation
spaCy_R49 spaCy_T49 spaCy_T50 amod progestin-only,preparation
spaCy_R5 spaCy_T5 spaCy_T7 det the,activity
spaCy_R50 spaCy_T50 spaCy_T47 dobj preparation,using
spaCy_R51 spaCy_T51 spaCy_T50 punct (,preparation
spaCy_R52 spaCy_T52 spaCy_T53 advmod usually,depo-medroxyprogesterone
spaCy_R53 spaCy_T53 spaCy_T54 amod depo-medroxyprogesterone,acetate
spaCy_R54 spaCy_T54 spaCy_T50 appos acetate,preparation
spaCy_R55 spaCy_T55 spaCy_T50 punct ),preparation
spaCy_R56 spaCy_T56 spaCy_T47 punct .,using
spaCy_R57 spaCy_T57 spaCy_T59 det The,group
spaCy_R58 spaCy_T58 spaCy_T59 amod second,group
spaCy_R59 spaCy_T59 spaCy_T65 nsubj group,used
spaCy_R6 spaCy_T6 spaCy_T7 amod mitotic,activity
spaCy_R60 spaCy_T60 spaCy_T59 prep of,group
spaCy_R61 spaCy_T61 spaCy_T62 amod age-matched,controls
spaCy_R62 spaCy_T62 spaCy_T60 pobj controls,of
spaCy_R63 spaCy_T63 spaCy_T65 aux had,used
spaCy_R64 spaCy_T64 spaCy_T65 neg never,used
spaCy_R65 spaCy_T65 spaCy_T65 ROOT used,used
spaCy_R66 spaCy_T66 spaCy_T68 det any,hormone
spaCy_R67 spaCy_T67 spaCy_T68 amod exogenous,hormone
spaCy_R68 spaCy_T68 spaCy_T65 dobj hormone,used
spaCy_R69 spaCy_T69 spaCy_T65 punct .,used
spaCy_R7 spaCy_T7 spaCy_T4 pobj activity,on
spaCy_R70 spaCy_T70 spaCy_T72 det The,group
spaCy_R71 spaCy_T71 spaCy_T72 amod third,group
spaCy_R72 spaCy_T72 spaCy_T76 nsubj group,using
spaCy_R73 spaCy_T73 spaCy_T72 prep of,group
spaCy_R74 spaCy_T74 spaCy_T73 pobj patients,of
spaCy_R75 spaCy_T75 spaCy_T76 aux was,using
spaCy_R76 spaCy_T76 spaCy_T76 ROOT using,using
spaCy_R77 spaCy_T77 spaCy_T81 det a,contraceptive
spaCy_R78 spaCy_T78 spaCy_T81 amod combined,contraceptive
spaCy_R79 spaCy_T79 spaCy_T81 nmod estrogen/progestin,contraceptive
spaCy_R8 spaCy_T8 spaCy_T7 prep of,activity
spaCy_R80 spaCy_T80 spaCy_T81 amod oral,contraceptive
spaCy_R81 spaCy_T81 spaCy_T76 dobj contraceptive,using
spaCy_R82 spaCy_T82 spaCy_T76 punct .,using
spaCy_R83 spaCy_T83 spaCy_T84 det The,results
spaCy_R84 spaCy_T84 spaCy_T85 nsubj results,show
spaCy_R85 spaCy_T85 spaCy_T116 ccomp show,were
spaCy_R86 spaCy_T86 spaCy_T92 mark that,have
spaCy_R87 spaCy_T87 spaCy_T92 nsubj patients,have
spaCy_R88 spaCy_T88 spaCy_T87 acl using,patients
spaCy_R89 spaCy_T89 spaCy_T91 det a,preparation
spaCy_R9 spaCy_T9 spaCy_T10 compound uterine,fibromyomas
spaCy_R90 spaCy_T90 spaCy_T91 amod progestin-only,preparation
spaCy_R91 spaCy_T91 spaCy_T88 dobj preparation,using
spaCy_R92 spaCy_T92 spaCy_T85 ccomp have,show
spaCy_R93 spaCy_T93 spaCy_T97 det a,activity
spaCy_R94 spaCy_T94 spaCy_T95 advmod significantly,higher
spaCy_R95 spaCy_T95 spaCy_T97 amod higher,activity
spaCy_R96 spaCy_T96 spaCy_T97 amod mitotic,activity
spaCy_R97 spaCy_T97 spaCy_T92 dobj activity,have
spaCy_R98 spaCy_T98 spaCy_T97 prep in,activity
spaCy_R99 spaCy_T99 spaCy_T98 pobj fibromyomas,in